The Clinical Efficacy and Safety of Four-Weekly Docetaxel as First-Line Therapy in Elderly Lung Cancer Patients with Squamous Cell Carcinoma

Jong-Hyun CHOI; Juwhan CHOI; Sang-Mi CHUNG; Jee-Youn OH; Young-Seok LEE; Kyung-Hoon MIN; Gyu-Young HUR; Jae-Jeong SHIM; Kyung-Ho KANG; Hyun-Kyung LEE; Sung-Yong LEE.
Tuberculosis and Respiratory Diseases ; : 211-216, 2019.
Artículo en Inglés | WPRIM | ID: wpr-919445

Documentos relacionados

  1. The Clinical Efficacy and Safety of Four-Weekly Docetaxel as First-Line Therapy in Elderly Lung Cancer Patients with Squamous Cell Carcinoma
  2. The Clinical Efficacy and Safety of Four-Weekly Docetaxel as First-Line Therapy in Elderly Lung Cancer Patients with Squamous Cell Carcinoma.